Fluidigm Corporation

3.71-0.2800-7.02%Vol 522.12K1Y Perf -15.29%
Apr 5th, 2022 16:00 DELAYED
BID3.69 ASK4.03
Open4.05 Previous Close3.99
Pre-Market- After-Market-
 - -  - -%
Target Price
10.00 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
★★★ —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
+ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
0.00 
Earnings Rating
Neutral
Market Cap286.41M 
Earnings Date
5th May 2022
Alpha0.00 Standard Deviation0.23
Beta1.14 

Today's Price Range

3.664.05

52W Range

2.677.51

5 Year PE Ratio Range

-4.90-3.30

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-
1 Month
0.00%
3 Months
2.49%
6 Months
-18.10%
1 Year
-15.29%
3 Years
-68.34%
5 Years
-32.42%
10 Years
-72.94%

TickerPriceChg.Chg.%
FLDM3.71-0.2800-7.02
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
0.90
1.50
0.52
1.18
-15.70
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
52.50
-45.80
-33.90
-47.80
-41.33
RevenueValueIndustryS&P 500US Markets
97.79M
1.27
4.84
6.59
Earnings HistoryEstimateReportedSurprise %
Q04 2021--0.06-
Q03 2021--0.13-
Q02 2021-0.15-0.17-13.33
Q01 2021-0.06-0.20-233.33
Q04 2020-0.09-0.18-100.00
Q03 2020-0.10-0.0370.00
Q02 2020-0.15-0.1220.00
Q01 2020-0.14-0.16-14.29
Earnings Per EndEstimateRevision %Trend
9/2021 QR-0.17-41.67Negative
12/2021 QR-0.10-11.11Negative
12/2021 FY-0.66-13.79Negative
12/2022 FY-0.38-18.75Negative
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume522.12K
Shares Outstanding77.20K
Shares Float66.59M
Trades Count5.65K
Dollar Volume1.96M
Avg. Volume0
Avg. Weekly Volume0
Avg. Monthly Volume0
Avg. Quarterly Volume0

Fluidigm Corporation (NASDAQ: FLDM) stock closed at 3.71 per share at the end of the most recent trading day (a -7.02% change compared to the prior day closing price) with a volume of 522.12K shares and market capitalization of 286.41M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 566 people. Fluidigm Corporation CEO is Stephen Christopher Linthwaite.

The one-year performance of Fluidigm Corporation stock is -15.29%, while year-to-date (YTD) performance is -5.36%. FLDM stock has a five-year performance of -32.42%. Its 52-week range is between 2.67 and 7.51, which gives FLDM stock a 52-week price range ratio of %

Fluidigm Corporation currently has a PE ratio of -4.80, a price-to-book (PB) ratio of 3.08, a price-to-sale (PS) ratio of 3.15, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -19.75%, a ROC of -25.27% and a ROE of -50.71%. The company’s profit margin is -41.33%, its EBITDA margin is -33.90%, and its revenue ttm is $97.79 Million , which makes it $1.27 revenue per share.

Of the last four earnings reports from Fluidigm Corporation, there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Fluidigm Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Fluidigm Corporation is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Fluidigm Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fluidigm Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fluidigm Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 17.31, ATR14 : 0.30, CCI20 : 58.22, Chaikin Money Flow : 0.02, MACD : 0.05, Money Flow Index : 72.60, ROC : -2.11, RSI : 46.20, STOCH (14,3) : 36.84, STOCH RSI : 0.00, UO : 50.99, Williams %R : -63.16), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fluidigm Corporation in the last 12-months were: Bradley Allen Kreger (Option Excercise at a value of $0), Colin McCracken (Option Excercise at a value of $0), Nicholas Khadder (Option Excercise at a value of $0), Stephen Christopher Linthwaite (Option Excercise at a value of $0), Vikram Jog (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
-
0.00

Fluidigm Corporation

Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific.

CEO: Stephen Christopher Linthwaite

Telephone: +1 650 266-6000

Address: 7000 Shoreline Court, South San Francisco 94080, CA, US

Number of employees: 566

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

42%58%

Bearish Bullish

73%27%

News

Stocktwits